Assignee profile:

NoNO Inc.

City:

Toronto

Country:

Canada

Published Applications:

33

Last publication date:

2022-06-09

Patent Grants:

27

Last grant date:

2024-02-27

Top Inventors for applications by NoNO Inc.

These are the the leading inventors for applications assigned to NoNO Inc.:

Recent patent applications by NoNO Inc.

NoNO Inc. based in Toronto, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-06-09 ✅ Patent 11,911,438 granted on 2024-02-27
US20220175880A1
Human necessities

Chloride salt of TAT-NR2B9C

#2 | 2022-06-09
US20220175879A1
Human necessities

THERAPY FOR SUBARACHNOID HEMORRHAGE AND ISCHEMIA

#3 | 2022-03-31
US20220096383A1
Human necessities

LYOPHILIZED FORMULATION OF TAT-NR2B9C WITH ACETYLATION SCAVENGER

#4 | 2021-10-07 ✅ Patent 11,878,044 granted on 2024-01-23
US20210308209A1
Human necessities

Combination therapy for ischemia

#5 | 2020-12-10 ✅ Patent 11,266,714 granted on 2022-03-08
US20200384071A1
Human necessities

Chloride salt of TAT-NR2B9C

#6 | 2020-07-16
US20200222492A1
Human necessities

Method of Reducing Injury to Mammalian Cells

#7 | 2020-04-23 ✅ Patent 11,338,015 granted on 2022-05-24
US20200121755A1
Human necessities

Therapy for subarachnoid hemorrhage and ischemia

#8 | 2019-09-12 ✅ Patent 10,912,817 granted on 2021-02-09
US20190275105A1
Human necessities

Prelyophilized, lyophilized and reconstituted formulations comprising TAT-NR2B9C with d-amino acids, histidine and trehalose

#9 | 2019-08-01
US20190231693A1
Human necessities

LYOPHILIZED FORMULATION OF TAT-NR2B9C WITH ACETYLATION SCAVENGER

#10 | 2019-06-13 ✅ Patent 10,758,589 granted on 2020-09-01
US20190175689A1
Human necessities

Chloride salt of TAT-NR2B9c

#11 | 2019-03-28 ✅ Patent 10,967,041 granted on 2021-04-06
US20190091283A1
Human necessities

Combination therapy for ischemia

#12 | 2017-02-16 ✅ Patent 10,046,060 granted on 2018-08-14
US20170043030A1
Human necessities

Co-administration of an agent linked to an internalization peptide with an anti-inflammatory

#13 | 2015-07-23 ✅ Patent 9,610,323 granted on 2017-04-04
US20150202253A1
Human necessities

Model systems and treatment regimes for treatment of neurological disease

#14 | 2015-05-07 ✅ Patent 9,433,685 granted on 2016-09-06
US20150126460A1
Human necessities

Co-administration of an agent linked to an internalization peptide with an anti-inflammatory

#15 | 2014-09-18 ✅ Patent 9,073,976 granted on 2015-07-07
US20140274906A1
Chemistry; metallurgy

ND2 peptides and methods of treating neurological disease

#16 | 2014-08-21 ✅ Patent 9,566,284 granted on 2017-02-14
US20140235619A1
Human necessities

Agents and methods for treating ischemic and other diseases

#17 | 2014-06-12
US20140162957A1
Human necessities

LYOPHILIZED FORMULATION OF TAT-NR2B9C

#18 | 2013-10-10 ✅ Patent 9,629,892 granted on 2017-04-25
US20130267470A1
Human necessities

Treatment of penetrative injury to the brain

#19 | 2013-07-04 ✅ Patent 9,061,070 granted on 2015-06-23
US20130172230A1
Human necessities

Treating stroke and other diseases without inhibiting N-type calcium channels

#20 | 2013-06-20 ✅ Patent 9,241,970 granted on 2016-01-26
US20130156704A1
Human necessities

Therapy for subarachnoid hemorrhage and ischemia

#21 | 2013-05-30 ✅ Patent 8,748,387 granted on 2014-06-10
US20130137641A1
Human necessities

Methods for treating pain

#22 | 2012-11-29
US20120302504A1
Human necessities

Method Of Reducing Injury To Mammalian Cells

#23 | 2012-10-25 ✅ Patent 8,940,699 granted on 2015-01-27
US20120269733A1
Human necessities

Model systems and treatment regimes for treatment of neurological disease

#24 | 2012-10-04 ✅ Patent 8,933,013 granted on 2015-01-13
US20120252731A1
Human necessities

Co-administration of an agent linked to an internalization peptide with an anti-inflammatory

#25 | 2012-04-05 ✅ Patent 8,536,129 granted on 2013-09-17
US20120083449A1
Human necessities

Treatment for anxiety

#26 | 2011-10-13 ✅ Patent 8,680,137 granted on 2014-03-25
US20110251182A1
Human necessities

Agents and methods for treating ischemic and other diseases

#27 | 2010-06-24 ✅ Patent 9,161,965 granted on 2015-10-20
US20100160240A1
Human necessities

Treatment for epilepsy

#28 | 2010-03-11 ✅ Patent 8,324,168 granted on 2012-12-04
US20100062985A1
Chemistry; metallurgy

Methods for treating pain

#29 | 2009-11-12 ✅ Patent 8,071,548 granted on 2011-12-06
US20090281037A1
Human necessities

Method of reducing injury to mammalian cells

#30 | 2009-07-09 ✅ Patent 8,080,518 granted on 2011-12-20
US20090176713A1
Human necessities

Co-administration of an agent linked to an internalization peptide with an anti-inflammatory

#31 | 2009-02-05 ✅ Patent 8,008,253 granted on 2011-08-30
US20090036376A1
Human necessities

Treatment for anxiety

#32 | 2008-11-06 ✅ Patent 8,288,345 granted on 2012-10-16
US20080274977A1
Chemistry; metallurgy

Treating stroke and other diseases without inhibiting N-type calcium channels

#33 | 2005-03-17 ✅ Patent 7,510,824 granted on 2009-03-31
US20050059597A1
Human necessities

Method of screening peptides useful in treating traumatic injury to the brain or spinal cord

Also check out NoNO Inc.'s (Toronto, Canada) applicant profile with 14 patent applications submitted.

AssigneeID:

27025 ⎘